Effects of Sleep Restriction on Female Soccer Players: Physical Performance, Muscle Damage, Inflammation, and BDNF Levels.
The Impact of Sleep Restriction on Physical Performance, Markers of Muscle Damage, Inflammation, and Brain-derived Neurotrophic Factor (BDNF) Levels in Female Soccer Players.
1 other identifier
interventional
20
1 country
2
Brief Summary
This research aims to investigate the interplay between menstrual cycles, sleep patterns, and athletic performance. Before experimental sessions, participants will maintain menstrual diaries for three months and complete assessments for sleep disorders and chronotype. Sleep duration will be objectively measured over five nights using actigraphy, complemented by sleep-related data from an actigraph and the Karolinska Sleep Diary. The study involves two sessions: normal sleep (based on habitual duration) and restricted sleep (reduced by 3 hours). Athletes will engage in a simulated match-play game before both sessions, followed by comprehensive performance tests the next day. Blood samples will be collected at three intervals to analyze hormonal profiles (including progesterone, and estradiol), markers of muscle damage, inflammation, stress (such as TNF-α, IL-6, CRP, myoglobin, cortisol, testosterone), and brain-derived neurotrophic factor (BDNF). On Day 1, pre- and post-training blood samples will be obtained, and participants will wear an actigraph, adhere to specified bedtime routines, and report activities (restricted sleep group). Day 2 involves completing a sleep diary, refraining from caffeine, responding to questionnaires assessing readiness to train and mood, and undergoing performance tests followed by self-reporting of pain levels and perceived exertion using established scales (VAS, RPE 6-20).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 25, 2023
CompletedFirst Submitted
Initial submission to the registry
December 12, 2023
CompletedFirst Posted
Study publicly available on registry
February 9, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedApril 11, 2024
February 1, 2024
6 months
December 12, 2023
April 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Countermovement jump
Vertical jump test performed by having an athlete quickly squat to a self-selected depth and then jump as high as possible.
1 day after night with or without intervention
Sprint test (0-30m)
1 day after night with or without intervention
Zig Zag test
1 day after night with or without intervention
Zig Zag test with ball
1 day after night with or without intervention
Yo-Yo Intermittent endurance test level I
1 day after night with or without intervention
Flanker task
1 day after night with or without intervention
Secondary Outcomes (5)
Mood (POMS)
1 day after night with or without intervention. During each experimental session. Before sports performance protocol
Pain (Pain scale)
1 day after night with or without intervention. Immediately after the last performance exercise in experimental sessions
Readiness-to-train questionnaire (RTT-Q)
1 day after night with or without intervention. During each experimental session. Before sports performance protocol
Rating perceived exertion (RPE)
1 day after night with or without intervention. Immediately after the last performance exercise in experimental sessions
Stress and recovery (SRSS)
1 day after night with or without intervention. In the morning, each experimental day and the day after
Other Outcomes (16)
Objective Sleep - Total sleep time
1 day after night with or without intervention. The night before and after the experimental sessions
Objective Sleep - Sleep efficiency
1 day after night with or without intervention. The night before and after the experimental sessions
Objective Sleep - WASO (Wake After Sleep Onset)
1 day after night with or without intervention. The night before and after the experimental sessions
- +13 more other outcomes
Study Arms (2)
Normal sleep
NO INTERVENTIONThe night before the experimental session, where participants will follow their habitual sleep-wake routines.
Sleep restriction
EXPERIMENTALThe night before the experimental session (with sleep restrictions (SR)), where participants will experience acute sleep restriction the night before the test session (i.e., 3 h of early sleep restriction versus normal sleep).
Interventions
Participants will experience a night of acute sleep restriction. During this night, they will sleep 3 hours less than usual.
Eligibility Criteria
You may qualify if:
- a minimum of 5 years of training experience
- practicing physical activity for the last 6 months at least 3 times per week for 2h
- current medical qualification for competitive sport
You may not qualify if:
- diseases that can have a bad influence on the menstrual cycle (e.g. polycystic ovarian syndrome, endometriosis);
- using hormonal contraception;
- regularity of the menstrual cycle.
- diagnosed cardiovascular, metabolic, gastrointestinal, or neurological diseases; movement, neuromuscular or musculoskeletal disorders;
- taking medications and supplements that may affect fitness test results; taking supplements that may affect biochemical test results
- sleep disorders (PSQI \>5)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
The Academy of Physical Education in Krakow
Krakow, 31-571, Poland
University School of Physical Education in Cracow
Krakow, 31-571, Poland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 12, 2023
First Posted
February 9, 2024
Study Start
November 25, 2023
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
April 11, 2024
Record last verified: 2024-02